Found 10 matching trials
Outcomes Comparison of Chronic Immune Thrombocytopenic Purpura (ITP) Patients Switched to Eltrombopag and Romiplostim N/A Chronic immune thrombocytopenic purpura (ITP) is characterized by low plate...
Show More Location
Multiple Locations
Learn More & Join Trial
Eltrombopag for Treatment of Fanconi Anemia PHASE2 An open-label, phase II study to assess the efficacy and safety of eltrombo...
Show More Location
Hospital Infantil Universitario Niño Jesús (HIUNJ)
Learn More & Join Trial
Thrombocytopenia and Bleeding in Wiskott-Aldrich Syndrome (WAS) Patients PHASE2 The purpose of this project is to describe the pathophysiology of thrombocy...
Show More Location
Weill Cornell Medical College
Learn More & Join Trial
Bioequivalence Study of Revolade® Eltrombopag 50 mg PHASE4 Status
Active Not Recruiting
Location
Centro de Atención e Investigación Médica
Learn More & Join Trial
A Phase II Dose-escalation Study Characterizing the PK of Eltrombopag in Pediatric Patients With Previously Untreated or Relapsed Severe Aplastic Anemia or Recurrent Aplastic Anemia PHASE2 This is a phase II, open label, multi-center, intra-patient dose escalation...
Show More Location
Phoenix Childrens Hospital
Learn More & Join Trial
Immunomodulation With Eltrombopag in ITP PHASE2 The study aims to investigate immunomodulatory effects of eltrombopag combi...
Show More Location
Aarau Cantonal Hospital, Division of Hematology
Learn More & Join Trial
Study of Efficacy, Safety and Immunogenicity of GP40141 (GEROPHARM, Russia) in Patients With Immune Thrombocytopenia PHASE3 The goal of this clinical trial is to demonstrate equivalent efficacy and c...
Show More Status
Active Not Recruiting
Location
Kaluga Regional Clinical Hospital
Learn More & Join Trial
REscuing Bone Marrow Function in Patients with AplaStic AnaEmia and Bone Marrow FaiLure Post AllogEneiC Transplantation 2 PHASE1 Allogeneic stem cell transplantation involves the transplanting of donor bl...
Show More Location
The Royal Melbourne Hospital
Learn More & Join Trial
Eltrombopag in Myelodysplastic Syndrome (MDS) Patients With Thrombocytopenia PHASE1 The purpose of this study is to evaluate the safety and efficacy of eltromb...
Show More Location
H. Lee Moffitt Cancer Center and Research Institute
Learn More & Join Trial
High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients With Splenomegaly PHASE2 To learn if giving ruxolitinib and busulfan before a stem cell transplant c...
Show More Location
MD Anderson Cancer Center
Learn More & Join Trial